D
QIAGEN N.V. QGEN
$39.48 $0.581.49%
Recommendation
Sell
Prev Close
$38.90
Volume
858,431
Avg Vol (90D)
1,076,417
Market Cap
$8.41B
Dividend & Yield
--
52-Week Range
$37.63 - $49.30
P/E (TTM)
93.83
EPS (TTM)
$0.4146
My Lists My Alerts
Rating
Reward
C
Fair
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Good
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now?
3/12/2025 - Zacks Investment Research
Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?
3/7/2025 - Zacks Investment Research
QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel
3/7/2025 - Zacks Investment Research
Qiagen (NYSE:QGEN) Sees Large Increase in Short Interest
3/7/2025 - MarketBeat
Qiagen NV (QGEN) Stock Price Up 3.55% on Mar 6
3/6/2025 - GuruFocus
Qiagen (QGEN, $38.55) RSI Indicator left the oversold zone on March 05, 2025
3/6/2025 - Tickeron - Technical Analysis
Qiagen (QGEN, $38.55) RSI Indicator left the oversold zone on March 05, 2025
3/6/2025 - Tickeron - Technical Analysis
Qiagen (NYSE:QGEN) Reaches New 12-Month Low - Should You Sell?
3/6/2025 - MarketBeat
Qiagen (QGEN, $38.55) RSI Indicator left the oversold zone on March 05, 2025
3/6/2025 - Tickeron - Technical Analysis
Qiagen announces FDA clearance for QIAstat-Dx Gastrointestinal Panel 2 Mini B
3/6/2025 - TipRanks Financial Blog
Qiagen announces FDA clearance for QIAstat-Dx Gastrointestinal Panel 2 Mini B
3/6/2025 - The Fly
Qiagen NV (QGEN) Secures FDA Clearance for New Gastrointestinal Panel
3/6/2025 - GuruFocus
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. ...
3/6/2025 - GuruFocus
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
3/6/2025 - Business Wire
Market is not liking Qiagen's (NYSE:QGEN) earnings decline as stock retreats 4.7% this week
3/5/2025 - Simply Wall St
Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now
3/3/2025 - Insider Monkey
10 Cash-Rich Mid Cap Stocks To Buy Now
3/3/2025 - Insider Monkey
Qiagen files patent infringement complaint against bioMerieux
3/3/2025 - The Fly
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations ...
3/3/2025 - GuruFocus
What is Zacks Research's Estimate for Qiagen Q1 Earnings?
3/3/2025 - MarketBeat
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
3/3/2025 - Business Wire
Qiagen (NYSE:QGEN) Sets New 52-Week Low - What's Next?
3/1/2025 - Ticker Report
Zacks Research Forecasts Qiagen's Q4 Earnings (NYSE:QGEN)
3/1/2025 - MarketBeat
Qiagen (NYSE:QGEN) Reaches New 12-Month Low - What's Next?
2/28/2025 - MarketBeat
Qiagen (QGEN, $38.4) RSI Indicator left the oversold zone on February 27, 2025
2/28/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$1.97B
EBITDA (TTM)
$386.39M
EBIT (TTM)
$188.81M
Net Income (TTM)
$92.93M
Balance Sheet
Total Assets (Q)
$6.27B
Total Debt (Q)
$2.01B
Total Liabilities (Q)
$2.74B
Book Value Per Share (Q)
$16.34
Cash Flow
Cash from Operations (TTM)
$633.41M
Cash from Investing (TTM)
-$300.90M
Cash from Financing (TTM)
$58.64M
Net Change in Cash (TTM)
$393.05M
Filings
Filing Date
Friday, November 8, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 10 and 14 (est)
Price History
Loading...
Beta
0.48
7-Day Total Return
2.41%
30-Day Total Return
-11.30%
60-Day Total Return
-13.03%
90-Day Total Return
-6.21%
Year to Date Total Return
-11.31%
1-Year Total Return
-10.30%
2-Year Total Return
-14.86%
3-Year Total Return
-12.60%
5-Year Total Return
-0.02%
52-week Low
Mar 04, 2025 - $37.63
52-week High
Jan 22, 2025 - $49.30
Valuation
Market Cap
$8.41B - Mid Cap
Enterprise Value
$8.65B
Price/Sales (TTM)
4.31
Price/Book (Q)
2.38
Dividends and Shares
Shares Outstanding
217.81M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.qiagen.com
Phone Number
31 77 355 6600
Address
Hulsterweg 82
Venlo, 5912 PL
Country
Netherlands
Year Founded
1984
Business Description
Sector
--
Industry
--
Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and... more
NYSE 03/14/2025 4:00PM Eastern Quotes delayed
Weiss Ratings